1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-52.04%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-84.03%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-153.45%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-154.62%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-190.27%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-190.28%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-190.28%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-77.63%
Negative 10Y revenue/share CAGR while 6203.T stands at 35.70%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-77.63%
Negative 5Y CAGR while 6203.T stands at 35.70%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-77.63%
Negative 3Y CAGR while 6203.T stands at 35.70%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
79.18%
Net income/share CAGR at 75-90% of 6203.T's 103.85%. Bill Ackman would press for strategic moves to boost long-term earnings.
79.18%
5Y net income/share CAGR at 75-90% of 6203.T's 103.85%. Bill Ackman would advocate improvements to match competitor’s profit expansion.
79.18%
3Y net income/share CAGR 75-90% of 6203.T's 103.85%. Bill Ackman might push for an operational plan to match or beat the competitor’s short-term growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Firm’s AR is declining while 6203.T shows 0.00%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
53.04%
Inventory growth well above 6203.T's 0.54%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
12.28%
Positive asset growth while 6203.T is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
-21.85%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
22.76%
We have some new debt while 6203.T reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.